Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial
Circulation · 20.02.2024 · 149 (8) · 562-573
DOI: 10.1161/circulationaha.123.066943 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 20.02.2024. Verfasst von Sung-Jin Hong und 21 weiteren Autor:innen. Beteiligte Einrichtung: Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (S.-J.H., S.-J.L., Y.-J.L., C.-M.A., J.-S.K., B.-K.K., Y.-G.K., D.C., M.-K.H.…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Drug-Eluting Stents, Myocardial Infarction, Stroke. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Biotronik.
Abstract (Originalsprache)
BACKGROUND: Stopping aspirin within 1 month after implantation of a drug-eluting stent for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome. The aim of this study was to investigate whether ticagrelor monotherapy after
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (S.-J.H., S.-J.L., Y.-J.L., C.-M.A., J.-S.K., B.-K.K., Y.-G.K., D.C., M.-K.H.).
- Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea (Y.S.).
- Wonkwang University Hospital, Iksan, Korea (K.H.Y.).
- Dankook University Hospital, Dankook University College of Medicine, Cheonan, Korea (T.S.K.).
- Ewha Womans University College of Medicine Seoul Hospital, Korea (S.S.).
- Inha University Hospital, Incheon, Korea (S.W.K.).
ORCID-Profile: Sung-Jin Hong, Seung-Jun Lee, Yongsung Suh, Kyeong Ho Yun, Tae Soo Kang, Sanghoon Shin, Sung Woo Kwon, Jun-Won Lee, Deok-Kyu Cho, Jong-Kwan Park, Woong Cheol Kang, Seunghwan Kim, Yong-Joon Lee, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong
Förderung
- Biotronik
Zitieren
APA
Hong, S. J., Lee, S. J., Suh, Y., Yun, K. H., Kang, T. S., Shin, S., Kwon, S. W., Lee, J. W., Cho, D. K., Park, J. K., Bae, J. W., Kang, W. C., Kim, S., Lee, Y. J., Ahn, C. M., Kim, J. S., Kim, B. K., Ko, Y. G., Choi, D., …, & T-PASS (Ticagrelor Monotherapy in Patients Treated With New-Generation Drug-Eluting Stents for Acute Coronary Syndrome) Investigators (2024). Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial. Circulation, 149(8), 562-573. https://doi.org/10.1161/circulationaha.123.066943
Vancouver
Hong SJ, Lee SJ, Suh Y, Yun KH, Kang TS, Shin S, et al. Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial. Circulation. 2024;149(8):562-573. doi:10.1161/circulationaha.123.066943
BibTeX
@article{Hong2024,
author = {Hong, Sung-Jin and Lee, Seung-Jun and Suh, Yongsung and Yun, Kyeong Ho and Kang, Tae Soo and Shin, Sanghoon and Kwon, Sung Woo and Lee, Jun-Won and Cho, Deok-Kyu and Park, Jong-Kwan and Bae, Jang-Whan and Kang, Woong Cheol and Kim, Seunghwan and Lee, Yong-Joon and Ahn, Chul-Min and Kim, Jung-Sun and Kim, Byeong-Keuk and Ko, Young-Guk and Choi, Donghoon and Jang, Yangsoo and Hong, Myeong-Ki and T-PASS (Ticagrelor Monotherapy in Patients Treated With New-Generation Drug-Eluting Stents for Acute Coronary Syndrome) Investigators, T-PASS (Ticagrelor Monotherapy in Patients Treated With New-Generation Drug-Eluting Stents for Acute Coronary Syndrome) Investigators},
title = {Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial},
journal = {Circulation},
year = {2024},
volume = {149},
number = {8},
pages = {562--573},
doi = {10.1161/circulationaha.123.066943}
}
EUVIMED